2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers
US11052086B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 11, 2017 |
| Grant date | Jul 6, 2021 |
| Priority date | — |
| Expiry date | May 11, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of using substituted 2-anilinopyrimidine derivatives, and pharmaceutically acceptable salts, solvates, or compositions, for the treatment of brain cancers, in particular EGFR-mediated metastatic brain cancer, are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.